查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年輸液泵全球市場
市場調查報告書
商品編碼
1140755

2022-2029 年輸液泵全球市場

Global Infusion Pumps Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

慢性病的增加正在推動市場增長

在美國，每 10 人中就有 6 人患有慢性病，例如心臟病、癌症、中風和糖尿病。根據疾病控制與預防中心2022年發布的報告，美國約有3730萬人患有糖尿病，約占美國人口的11.3%。其中，已確診2870萬人，其中成年人2850萬人，成年人850萬人（23.0%的成年人未確診）。共有 9600 萬 18 歲以上的人處於糖尿病前期，約占美國成年人口的 38%。 2640 萬（48.8%）65 歲及以上的美國人處於糖尿病前期。糖尿病是美國第七大死亡原因。此外，冠心病是美國最常見的心臟病，據說2020年將有約382,820人死亡。大約 2010 萬 20 歲以上的成年人患有冠心病（約 7.2%）。到 2020 年，約十分之二的 CAD 死亡將發生在 65 歲以下的成年人中。

但是，嚴格的法規、產品召回以及改進型輸液泵的採用增加正在阻礙市場增長。例如，2020 年 3 月 6 日，BD 召回了 Alaris System 輸液泵。根據 FDA 的說法，這被歸類為 I 類召回，這是最嚴重的召回類型之一。使用這些設備可能會導致嚴重傷害或死亡。由於多個系統、軟件和使用錯誤，BD/Care Fusion 303 召回了 Alaris 輸液泵系統和模塊。

地理滲透。

北美是預測期內的主要地區。

北美有很高的採用率來治療慢性病的專用輸液泵、慢性病患病率的增加、老年人口的增長以及該地區許多大型醫院的存在。主導了全球市場並在2021年佔據了最大的市場份額。加拿大大量的胰島素治療推動了北美藥物輸送輸液系統市場。根據 Statista 的數據，到 2021 年，大約 7.3% 的加拿大人將報告有醫療保健提供者診斷出的糖尿病。主要注射和輸液系統製造商的地域擴張正在推動北美輸液泵市場。輸液系統的推出一直是推動北美藥物輸送輸液系統市場的關鍵因素。例如，2022 年 8 月，創新給藥技術的領導者百特國際公司宣布美國食品藥品監督管理局批准了帶有 Dose IQ 安全軟件的新型 Novum IQ 注射器輸液泵 (SYR)，它代表了百特在輸液療法。這些注射器輸液泵通常用於兒科、新生兒、麻醉和其他醫療環境，以低速和精確地輸送少量液體。

競爭格局。

全球輸液泵市場分散，有大量國際和地區參與者。市場上的主要參與者包括 B. Braun、Medtronic Plc、F. Hoffmann-La Roche Ltd.、Smiths Medical、Becton、Dickinson And Company、Baxter International Inc、Terumo Corporation、Teleflex, Inc、Mindray Medical International Limited、Fresenius Kabi 等。主要參與者正在採取各種增長戰略，如業務擴張、併購、合作夥伴關係、產品發布、聯盟等，為全球輸液泵市場的增長做出貢獻。例如，2020 年 2 月 27 日，LTR Medical 決定與 Woo Young Medical 簽訂獨家分銷協議，將其新一代彈性體注射技術分銷到澳大利亞市場。 Woo Young Medical 是全球動態輸液技術的領導者之一，總部位於韓國。圖為 LTR Medical 首席執行官 Lee Rodne 和 Woo Young Medical 首席運營官兼總裁 Brian Cha。 2020 年 2 月 24 日，Unity Therapeutics Corporation 和 DEKA Research & Development Corp. 發布了 FDA（美國食品和藥物管理局）510(k) 用於 Remodulin（曲前列素）注射液的 Unity 皮下給藥系統，稱為 Remunity(TM) 泵. 該批准允許 United Therapeutics 推出該系統，該□□系統帶有來自專業藥房的預裝藥罐。 2020年1月，美敦力還為其鞘內給藥系統“Syncromed II”推出了基於雲的數據管理軟件“Efficio”。它使臨床醫生能夠有效地管理有針對性的藥物輸送泵實踐，以治療患有慢性疼痛、癌症和嚴重痙攣的患者。

全球輸液泵市場報告提供對大約 44 個市場數據表、43 個圖表和 170 頁的訪問。

內容

第 1 章調查方法及範圍

  • 調查方法
  • 市場範圍

第 2 章主要趨勢和發展

第 3 章執行摘要

  • 按產品類型劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 促進因素
    • 抑制因素
    • 商機
  • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 價值鏈分析
  • 專利分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措

第 7 章按產品類型

  • 設備和泵
  • 人體植入式輸液泵
  • 胰島素輸液泵
  • 注射器式輸液泵
  • 容積式輸液泵
  • 腸內給藥泵
  • 門診輸液泵
  • 其他

第 8 章按應用程序

  • 糖尿病專區
  • 化療/腫瘤學
  • 腸胃科
  • 鎮痛和疼痛管理
  • 兒科/新生兒科
  • 血液學
  • 其他

第 9 章最終用戶

  • 醫院和診所
  • 門診護理設施
  • 家庭醫療機構
  • 學術和研究機構

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 競爭對手戰略分析
  • 市場情況/份額分析
  • 併購分析

第 12 章公司簡介

  • B. Braun
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
  • Smiths Medical
  • Becton, Dickinson, and Company
  • Baxter International Inc
  • Terumo Corporation
  • Teleflex, Inc.
  • Mindray Medical International Limited
  • Fresenius Kabi

第 13 章 DataM

簡介目錄
Product Code: DMPH2889

Market Overview

Infusion Pumps Market is forecasted to reach at a CAGR of 9% during the forecast period (2022-2029).

Infusion pumps are medical devices that deliver fluids, such as nutrients and medications, into the patient's body in controlled amounts. Infusion pumps have widespread use in clinical settings such as hospitals, nursing homes, and the home. They offer several advantages over manual administration, such as delivering fluids in small quantities and delivering fluids at precisely programmed rates or automated intervals. They deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. The global infusion pump market is growing due to several factors, such as the rising incidence of chronic diseases with an increasing geriatric population, growing demand for ambulatory infusion pumps, technological advancements in devices & accessories, and the increasing number of surgical procedures performed.

Market Dynamics: The rising incidences of chronic diseases drive the market growth

In the United States, about six in ten live with chronic diseases, like heart disease, cancer, stroke, or diabetes. According to the report published by the Centre for disease control and prevention in 2022, In the United States, around 37.3 million people have diabetes, which is around 11.3% of the United States population. Among these, 28.7 million people were diagnosed; including 28.5 million adults and 8.5 million people (23.0% of adults are undiagnosed). A total 96 million people aged 18 years or older have prediabetes, around 38% of the adult US population. 26.4 million People in the United States aged 65 years or older (48.8%) have prediabetes. Diabetes is the seventh leading cause of death in the United States. Also, coronary heart disorder is the most common type of heart disease in the United States, killing about 382,820 people in 2020. About 20.1 million adults age 20 and older have coronary heart disorder (about 7.2%). In 2020, about 2 in 10 deaths from CAD happened in adults less than 65 years old.

However, stringent regulations, product recalls, and the rising adoption of refurbished infusion pumps hinder the market's growth. For instance, on March 6th, 2020, BD recalled Alaris System infusion pumps. According to the FDA, this has been identified as the Class I recall, one of the most serious types of recall. The use of these devices may cause serious injuries or death. BD/Care Fusion 303 recalls the Alaris Infusion Pump System and Modules due to multiple system errors, software errors, and use-related errors.

Market Segmentation: The insulin infusion pumps segment is projected to be the dominant segment in the market during the forecast period.

By product, the infusion pumps market is segmented into pumps & devices & accessories & consumables.

The insulin infusion pumps segment is estimated to grow at the fastest CAGR during the forecast period. The insulin pump provides continuous delivery of short-acting insulin all day long. The insulin pump substitutes the need for long-acting insulin. An insulin pump also replaces the need for multiple daily injections with a continuous insulin infusion and improves your blood sugar levels. Insulin infusion pumps are made of Teflon or steel and attach to your skin with an adhesive patch. The pump's underside is a short, thin tube (cannula) inserted in the skin with a small needle housed within the cannula to deliver insulin into a layer of fatty tissue. The increasing regulatory approvals from the national governing bodies for insulin infusion pumps drive the global drug delivery infusion system market. For instance, in August 2021, Lilly's insulin lispro-aabc injection (Lyumjev) 100 units/mL was granted FDA approval to improve glycemic control in adults with type 1 and type 2 diabetes, including administration via continuous subcutaneous insulin infusion with an insulin pump. Insulin pumps are an important delivery option for people with diabetes.

Based on application, the infusion pumps market is segmented into diabetes, gastroenterology, chemotherapy/oncology, analgesia/pain management, hematology, pediatrics/neonatology, and others.

Among these, the diabetes segment is estimated to grow at the highest CAGR over the forecast period, owing to the rising prevalence of diabetes and increasing demand for insulin pumps to manage diabetes in-home care. The launch of a new product for diabetes is driving the global drug delivery infusion system market.

Geographical Penetration: North America is the dominating region during the forecast period.

North America dominated the global infusion pumps market and accounted for the largest market share in 2021, owing to the high adoption of specialty infusion pumps to treat chronic diseases, increasing prevalence of chronic diseases, rising geriatric population, and the presence of many large hospitals in the region. The huge number of insulin therapy in Canada is driving the North American drug delivery infusion system market. According to Statista, in 2021, around 7.3 percent of Canadians reported that they had been diagnosed by a health professional as having diabetes. The geographical expansion of leading injection and infusion systems manufacturers drives the North American infusion pumps market. The infusion system's launch is a key factor driving the North American drug delivery infusion system market. For instance, in August 2022, Baxter International Inc., a leader in innovative technology for medication delivery, announced U.S. Food and Drug Administration approval for its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter's latest developments for infusion therapy. These syringe infusion pumps are typically used to precisely deliver small amounts of fluid at low rates, often in pediatric, neonatal or anesthesia care settings.

Competitive Landscape:

The global infusion pumps market is fragmented, with a large number of international and local players. Some of the market's major players include B. Braun, Medtronic Plc, F. Hoffmann-La Roche Ltd., Smiths Medical, Becton, Dickinson And Company, Baxter International Inc., Terumo Corporation, Teleflex, Inc., Mindray Medical International Limited, Fresenius Kabi, among others. The key players are adopting various growth strategies such as expansion, mergers & acquisitions, partnerships, product launches, and collaborations, contributing to the growth of the Infusion Pumps market globally. For instance, On February 27th, 2020, LTR Medical entered an exclusive distribution agreement with Woo Young Medical to distribute their new generation of elastomeric infusion technologies into the Australian market. Woo Young Medical is one of the global leaders in ambulatory infusion technology, based in Korea. Pictured here are Lee Rodne, CEO of LTR Medical, and Brian Cha, COO/President of Woo Young Medical. On February 24th, 2020, United Therapeutics Corporation and DEKA Research & Development Corp. received 510(k) clearance by the U.S. Food and Drug Administration (FDA) related to the Unity Subcutaneous Delivery System for Remodulin (treprostinil) Injection, also referred to as the Remunity™ pump, enabling United Therapeutics to launch the system using drug reservoirs that specialty pharmacies have prefilled. Also, In January 2020, Medtronic launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. It enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.

The global infusion pumps market report would provide an access to approximately 44 market data tables, 43 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Type Segment
    • 7.1.2. Market attractiveness index, By Product Type Segment
  • 7.2. Devices & Pumps *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Implantable Infusion Pumps
  • 7.4. Insulin Infusion Pumps
  • 7.5. Syringe Infusion Pumps
  • 7.6. Volumetric Infusion Pumps
  • 7.7. Enteral Infusion Pumps
  • 7.8. Ambulatory Infusion Pumps
  • 7.9. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
    • 8.1.2. Market attractiveness index, By Application Segment
  • 8.2. Diabetes *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Chemotherapy/Oncology
  • 8.4. Gastroenterology
  • 8.5. Analgesia/Pain Management
  • 8.6. Pediatrics/Neonatology
  • 8.7. Hematology
  • 8.8. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By End-User Segment
    • 9.1.2. Market attractiveness index, By End-User Segment
  • 9.2. Hospitals & Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Care Settings
  • 9.4. Home Care Settings
  • 9.5. Academic & Research Institutes

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key region-specific dynamics
    • 10.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive scenario
  • 11.2. Competitor strategy analysis
  • 11.3. Market positioning/share analysis
  • 11.4. Mergers and acquisitions analysis

12. Company Profiles

  • 12.1. B. Braun*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Medtronic PLC
  • 12.3. F. Hoffmann-La Roche Ltd.
  • 12.4. Smiths Medical
  • 12.5. Becton, Dickinson, and Company
  • 12.6. Baxter International Inc
  • 12.7. Terumo Corporation
  • 12.8. Teleflex, Inc.
  • 12.9. Mindray Medical International Limited
  • 12.10. Fresenius Kabi
  • List not Exhaustive*

13. DataM

  • 13.1. Appendix
  • 13.2. About us and services
  • 13.3. Contact us